Gossamer Bio (FRA:4GB) Accumulated Depreciation : €-4.99 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Gossamer Bio Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Gossamer Bio's quarterly accumulated depreciation increased from Sep. 2023 (€-4.74 Mil) to Dec. 2023 (€-4.98 Mil) and increased from Dec. 2023 (€-4.98 Mil) to Mar. 2024 (€-4.99 Mil).

Gossamer Bio's annual accumulated depreciation increased from Dec. 2021 (€-3.79 Mil) to Dec. 2022 (€-5.77 Mil) but then stayed the same from Dec. 2022 (€-5.77 Mil) to Dec. 2023 (€-4.98 Mil).

Gossamer Bio Accumulated Depreciation Historical Data

The historical data trend for Gossamer Bio's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Accumulated Depreciation Chart

Gossamer Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-1.09

-2.16

-3.79

-5.77

-4.98

Gossamer Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-6.14	-6.50	-4.74	-4.98	-4.99

Gossamer Bio Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Gossamer Bio Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Gossamer Bio's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Gossamer Bio (FRA:4GB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (FRA:4GB) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

GOSS:USA 4GB:Germany

Address

3013 Science Park Road, Suite 200, San Diego, CA, USA, 92121

Website

https://www.gossamerbio.com

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio (FRA:4GB) Headlines

No Headlines